No evidence for modulation of endothelial nitric oxide synthase by the olive oil polyphenol hydroxytyrosol in human endothelial cells

Atherosclerosis

Volumn 195, Issue 1, 2007, Pages

  Schmitt, Christoph A ^a   Handler, Norbert ^a   Heiss, Elke H ^a   Erker, Thomas ^a   Dirsch, Verena M ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Atherosclerosis; eNOS; Hydroxytyrosol; Nitric oxide; Olive oil

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; OLIVE OIL; POLYPHENOL DERIVATIVE; POLYPHENOL HYDROXYTYROSOL; UNCLASSIFIED DRUG;

ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; PRIORITY JOURNAL; RED WINE; STATISTICAL SIGNIFICANCE; TRANSACTIVATION;

CARDIOVASCULAR DISEASES; CELL LINE; CITRULLINE; ENDOTHELIAL CELLS; FLAVONOIDS; GENES, REPORTER; HUMANS; INFLAMMATION; LUCIFERASES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHENOLS; PHENYLETHYL ALCOHOL; PLANT OILS; TRANS-ACTIVATION (GENETICS); WINE;

EID: 35248857836     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.02.024     Document Type: Article

References (37)

1. Forstermann U. Janus-faced role of endothelial NO synthase in vascular disease: uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal. Biol Chem 387 (2006) 1521-1533
2. Oess S., Icking A., Fulton D., Govers R., and Muller-Esterl W. Subcellular targeting and trafficking of nitric oxide synthases. Biochem J 396 (2006) 401-409
3. Li H., Wallerath T., and Forstermann U. Physiological mechanisms regulating the expression of endothelial-type NO synthase. Nitric Oxide 7 (2002) 132-147
4. Leikert J.F., Rathel T.R., Wohlfart P., et al. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 106 (2002) 1614-1617
5. Wallerath T., Deckert G., Ternes T., et al. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106 (2002) 1652-1658
6. Wallerath T., Li H., Godtel-Ambrust U., Schwarz P.M., and Forstermann U. A blend of polyphenolic compounds explains the stimulatory effect of red wine on human endothelial NO synthase. Nitric Oxide 12 (2005) 97-104
7. Rathel T.R., Leikert J.F., Vollmar A.M., and Dirsch V.M. The soy isoflavone genistein induces a late but sustained activation of the endothelial nitric oxide-synthase system in vitro. Br J Pharmacol 144 (2005) 394-399
8. Lorenz M., Wessler S., Follmann E., et al. A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation. J Biol Chem 279 (2004) 6190-6195
9. Leung K.W., Cheng Y.K., Mak N.K., et al. Signaling pathway of ginsenoside-Rg1 leading to nitric oxide production in endothelial cells. FEBS Lett 580 (2006) 3211-3216
10. de Lorgeril M., Salen P., Martin J.L., et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 99 (1999) 779-785
11. Visioli F., Borsani L., and Galli C. Diet and prevention of coronary heart disease: the potential role of phytochemicals. Cardiovasc Res 47 (2000) 419-425
12. Covas M.I., Nyyssonen K., Poulsen H.E., et al. The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. Ann Intern Med 145 (2006) 333-341
13. Visioli F., Bellomo G., and Galli C. Free radical-scavenging properties of olive oil polyphenols. Biochem Biophys Res Commun 247 (1998) 60-64
14. Covas M.I., de la Torre K., Farre-Albaladejo M., et al. Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans. Free Radic Biol Med 40 (2006) 608-616
15. Visioli F., Bellomo G., Montedoro G., and Galli C. Low density lipoprotein oxidation is inhibited in vitro by olive oil constituents. Atherosclerosis 117 (1995) 25-32
16. Bogani P., Galli C., Villa M., and Visioli F. Postprandial anti-inflammatory and antioxidant effects of extra virgin olive oil. Atherosclerosis 190 (2007) 181-186
17. Gonzalez-Santiago M., Martin-Bautista E., Carrero J.J., et al. One-month administration of hydroxytyrosol, a phenolic antioxidant present in olive oil, to hyperlipemic rabbits improves blood lipid profile, antioxidant status and reduces atherosclerosis development. Atherosclerosis 188 (2006) 35-42
18. Maiuri M.C., De Stefano D., Di Meglio P., et al. Hydroxytyrosol, a phenolic compound from virgin olive oil, prevents macrophage activation. N-S Arch Pharmacol 371 (2005) 457-465
19. Carluccio M.A., Siculella L., Ancora M.A., et al. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol 23 (2003) 622-629
20. Perez-Jimenez F., Alvarez de Cienfuegos G., Badimon L., et al. International conference on the healthy effect of virgin olive oil. Eur J Clin Invest 35 (2005) 421-424
21. Ruano J., Lopez-Miranda J., Fuentes F., et al. Phenolic content of virgin olive oil improves ischemic reactive hyperemia in hypercholesterolemic patients. J Am Coll Cardiol 46 (2005) 1864-1868
22. de la Torre R., Covas M.I., Pujadas M.A., Fito M., and Farre M. Is dopamine behind the health benefits of red wine?. Eur J Nutr 45 (2006) 307-310
23. Gardiner J.M., Bryce M.R., Bates P.A., and Hursthouse M.B. Cephalotoxine analogs: stereospecific synthesis of spiro-fused 3-benzazepine and 1,3-benzodiazepin derivatives. J Org Chem 55 (1990) 1261-1266
24. Narayanan J., Hayakawa Y., Fan J., and Kirk K.L. Convenient syntheses of biogenic aldehydes 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde. Bioorg Chem 31 (2003) 191-197
25. Edgell C.J., McDonald C.C., and Graham J.B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA 80 (1983) 3734-3737
26. Li H., Oehrlein S.A., Wallerath T., et al. Activation of protein kinase C alpha and/or epsilon enhances transcription of the human endothelial nitric oxide synthase gene. Mol Pharmacol 53 (1998) 630-637
27. Leikert J.F., Rathel T.R., Muller C., Vollmar A.M., and Dirsch V.M. Reliable in vitro measurement of nitric oxide released from endothelial cells using low concentrations of the fluorescent probe 4,5-diaminofluorescein. FEBS Lett 506 (2001) 131-134
28. Jackson T.S., Xu A., Vita J.A., and Keaney Jr. J.F. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 83 (1998) 916-922
29. Spiecker M., Peng H.B., and Liao J.K. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkappaBalpha. J Biol Chem 272 (1997) 30969-30974
30. Rietjens S., Bast A., de Vente J., and Haenen G. The olive oil antioxidant hydroxytyrosol efficiently protects against the oxidative stress induced impairment of the NO{middle dot} response of isolated rat aorta. Am J Physiol Heart Circ Physiol (2006)
31. Davis M.E., Grumbach I.M., Fukai T., Cutchins A., and Harrison D.G. Shear stress regulates endothelial nitric-oxide synthase promoter activity through nuclear factor kappaB binding. J Biol Chem 279 (2004) 163-168
32. Ferrero M.E., Bertelli A.E., Fulgenzi A., et al. Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium. Am J Clin Nutr 68 (1998) 1208-1214
33. Acin S., Navarro M.A., Arbones-Mainar J.M., et al. Hydroxytyrosol administration enhances atherosclerotic lesion development in apo E deficient mice. J Biochem (Tokyo) 140 (2006) 383-391
34. Covas M.I., Ruiz-Gutiérrez V., De la Torre R., et al. Minor components of olive oil: evidence to date of health benefits in humans. Nutr Rev 64 (2006) 20-30
35. Visioli F., Galli C., Grande S., et al. Hydroxytyrosol excretion differs between rats and humans and depends on the vehicle of administration. J Nutr 133 (2003) 2612-2615
36. Shaul P.W. Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis. J Physiol 547 (2003) 21-33
37. Smith A.R., Visioli F., Frei B., and Hagen T.M. Age-related changes in endothelial nitric oxide synthase phosphorylation and nitric oxide dependent vasodilation: evidence for a novel mechanism involving sphingomyelinase and ceramide-activated phosphatase 2A. Aging Cell 5 (2006) 391-400